Boston Scientific Gains J&J Device Chief As President, Then CEO
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific will have three successive CEOs over the next 14 months in a transition process that will end with the current device and diagnostics business chief for long-time rival Johnson & Johnson taking the helm.